May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Prevalence of Late Age–Related Maculopathy (AMD) in Greece. Thessaloniki Eye Study
Author Affiliations & Notes
  • E. Anastasopoulos
    Center of Epidemiology, Jules Stein Eye Institute/UCLA, Los Angeles, CA
    Department of Ophthalmology, Research Laboratory, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • F. Topouzis
    Department of Ophthalmology, Research Laboratory, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • M. Wilson
    Texas Tech University, Lubbock, TX
  • A. Harris
    Indiana University School of Medicine, Indianapolis, IN
  • F. Yu
    Center of Epidemiology, Jules Stein Eye Institute/UCLA, Los Angeles, CA
  • A. Koskosas
    Department of Ophthalmology, Research Laboratory, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • T. Pappas
    Department of Ophthalmology, Research Laboratory, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • L. Mavroudis
    Department of Ophthalmology, Research Laboratory, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • G. Karkamani
    Department of Ophthalmology, Research Laboratory, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • A.L. Coleman
    Center of Epidemiology, Jules Stein Eye Institute/UCLA, Los Angeles, CA
  • Footnotes
    Commercial Relationships  E. Anastasopoulos, None; F. Topouzis, None; M. Wilson, None; A. Harris, None; F. Yu, None; A. Koskosas, None; T. Pappas, None; L. Mavroudis, None; G. Karkamani, None; A.L. Coleman, None.
  • Footnotes
    Support  IGA, London, UK, UCLA CEE, LA, CA, HFF, Creighton Univ, Omaha,NE, Texas Tech Univ, TX ,unrestricted grants: Pfizer, Inc. New York, NY, Pharmacia Hellas, Greece Merck&Co, Inc,NJ, Novartis Hellas Greece
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2210. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. Anastasopoulos, F. Topouzis, M. Wilson, A. Harris, F. Yu, A. Koskosas, T. Pappas, L. Mavroudis, G. Karkamani, A.L. Coleman; Prevalence of Late Age–Related Maculopathy (AMD) in Greece. Thessaloniki Eye Study . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2210.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To present the prevalence estimates of late age–related maculopathy (AMD) in a well–defined, elderly population in Thessaloniki, Greece

Methods: : Subjects 60 years of age or older, randomly identified from municipality registers of the city of Thessaloniki, were invited to participate in the Thessaloniki Eye Study (TES), in which an extensive ophthalmologic examination was performed by trained ophthalmologists. The examination included measurement of habitual and best–corrected visual acuity, a dilated slit lamp examination, and evaluation of the macula with slit lamp biomicroscopy . AMD was defined, according to the International Classification and Grading System, as the presence of either geographic atrophy (GA) or neovascular (NV) AMD in either eye of a subject.

Results: : From October 2000 to March 2005, 2554 subjects were examined in the clinic or in their homes (participation rate 71%). The prevalence of AMD was 2.5%, while the prevalence of NV AMD and GA were 1.4% and 1.3%, respectively. AMD occurred bilaterally in 40% of subjects with AMD. Age was associated with greater prevalence of AMD. No statistically significant sex differences were found.

Conclusions: : The prevalence of AMD in people over 60 years of age in Greece is similar to the prevalence in other European–derived populations in Australia, the United States and Northern Europe.

Keywords: age-related macular degeneration • clinical (human) or epidemiologic studies: prevalence/incidence 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×